We report here a new function of Akt1, the regulation of ploidy in vascular smooth muscle. We show that Akt1 protein levels and activity are elevated in VSMCs at capacitance arteries of hypertensive rats. Since Akt1 is well known to provide signals that promote cell growth (44) (45) (46) (47) , we hypothesized that an increase in Akt1 activity may be involved in the onset of VSMC polyploidization. To test this hypothesis, we generated populations of primary VSMCs overexpressing a wildtype or a catalytic inactive Akt1 mutant and investigated the ability of these cells to control the progression of mitosis. VSMCs with enhanced Akt1 expression underwent unscheduled cyclin B degradation and reentered the cell cycle at a tetraploid DNA content, generating polyploid and hypertrophic cells. Furthermore, angiotensin II, an activator of Akt1 in VSMCs (26, (48) (49) (50) , induced Akt1-dependent VSMC polyploidization. These results demonstrate that Akt1 is a positive regulator of the progression of mitosis in VSMCs and implicate this protein in the mechanism of hypertension-related VSMC polyploidization and hypertrophy.
Methods
Animals and histology. Spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) rats were obtained from Charles River Laboratories (Wilmington, Massachusetts, USA). Zucker rats were obtained from Harland Sprague Dawley (Indianapolis, Indiana, USA). Two-kidney oneclip Goldblatt WKY rats were purchased from Taconic Farms (Germantown, New York, USA). Rats were sacrificed in accordance with American Veterinary Medicine Association recommendations and tissues rapidly processed for culture, histology, or extract preparation. Blood pressures were determined using tail cuffs and a programmed electrosphygmomanometer following the recommendations of the manufacturer (Narco Bio-Systems, Austin, Texas, USA). For histology, arteries were fixed in 10% formalin for a minimum of 12 hours and embedded in paraffin. Consecutive 5-µm tissue sections were deparaffinized in xylene, rehydrated in a series of increasingly diluted solutions of ethanol, and processed for Feulgen and periodic acid-Schiff-hematoxylin (PAShematoxylin) staining (51) . Quantitative DNA analysis was carried out using a CAS200 microdensitometer (Becton Dickinson, San Jose, California, USA). Three hundred VSMC nuclei were quantified per sample. At our measurement conditions and using human bladder cells as standard, we regarded VSMCs with a DNA content of 6-9 pg DNA per nucleus as diploid cells, cells with 12-18 pg DNA per nucleus as tetraploid, and cells with a DNA content over 18 pg as octaploid (8, 52) . Immunohistochemistry was carried out using Vectastain-ABC kits (Vector Laboratories, Burlingame, Massachusetts, USA) and Akt1 Ab (Santa Cruz Biotechnologies, Santa Cruz, California, USA) at a dilution of 1:50.
Isolation, infection, and culture of VSMCs. VSMCs were isolated following the method described in detail by Owens and coworkers (53) . Briefly, vessels were excised, placed in PBS, and adhering fat and connective tissue removed by dissection. Vessels were then preincubated at 37°C for 15 minutes in PBS with 1 mg/ml collagenase II (Worthington, Freehold, New Jersey, USA), 0.5 mg/ml elastase I (Worthington), 100 U/ml penicillin, and streptomycin (100 µg/ml; protease solution) in 5% CO 2 . Their adventitia was then carefully removed under the dissecting microscope. Vessels were subsequently opened longitudinally and the luminal endothelia scraped with forceps. The smooth muscle layer was then minced into 2-mm sections and digested in fresh protease solution for 2 hours, as above. The cellular suspension was filtered through a mess and cells were pelleted, washed three times in PBS, seeded at a density of 3,500 cells/cm 2 , and grown in DMEM media supplemented with 10% FBS and penicillin/streptomycin (Life Technologies Inc., Gaithersburg, Maryland, USA). The VSMC phenotype was verified by immunostaining using specific Ab's against smooth muscle α-actin and smooth muscle myosin heavy chain, as described previously (53, 54) . Population-doubling times were determined by plating VSMCs at low density and determining the cell number over several days. For that purpose, cell counts from several dishes were averaged daily using a Coulter model ZF cell counter beginning 1 day after plating.
Replication-defective adenovirus constructs expressing mouse Akt1 proteins under the control of the cytomegalovirus (CMV) promoter were as described previously (25, 35) . The AA Akt1 construct contains the mutations T308A and S473A and cannot be activated by phosphorylation (55) . Ad-β Gal expresses the bacterial β-galactosidase gene from the CMV promoter. Adenoviral constructs were amplified in 293 cells and purified by ultracentrifugation through a CsCl gradient. VSMCs were infected for 24 hours at a moi of 1-100 (25, 35) .
Akt1 kinase assays. Akt1 activity was measured using the method described by Tsichlis and coworkers (24) . Briefly, vascular smooth muscle was disrupted using a Branson sonifier at setting 4 in lysis buffer (1% NP-40, 10% glycerol, 137 mM NaCl, 20 mM Tris-HCl at pH 7.4) containing 5 µg/ml of the protease inhibitors aprotinin and leupeptin, 1 mM PMSF, 1 mM NaF, 1 mM sodium pyrophosphate, and 1 mM sodium orthovanadate. Lysates (100 µg protein) were precleared by centrifugation and preabsorbed with protein A/G agarose slurry. Immunoprecipitation of Akt1 was carried out for 4 hours using a specific Ab (Santa Cruz Biotechnologies). Immunoprecipitates were washed three times with lysis buffer, once with water, and once with kinase buffer. Kinase assays were performed in Akt kinase buffer (20 mM HEPES-NaOH, 10 mM magnesium chloride, and 10 mM manganese chloride). Kinase activity was assayed for 20 minutes at 30°C in a 30-µl volume of kinase buffer with 5 µM ATP, 100 µg/ml histone 2B, and 20 µCi [γ -32 ]ATP per sample. Reactions were stopped by an equal volume of 2× SDS buffer-PAGE sample buffer. The products of the in vitro kinase assay were analyzed by 15% SDS/PAGE and exposure to PhosphorImager screens.
VSMC fractionation in Percoll density gradients. Cell fractionation was performed as described previously (56) using Percoll gradients (Pharmacia Biotech AB, Uppsala, Sweden) diluted in PBS, pH 7.4, containing 5 mg/ml BSA (Sigma Chemical Co., St. Louis, Missouri, USA). Thirty to seventy percent gradients were prepared fresh in 15-ml centrifuge tubes by layering from below, upwards 1 ml, 70%; 3 ml, 52%; 4 ml, 42%; and 5 ml, 30% Percoll. VSMCs (10 7 Akt1 wild-type transduced) were resuspended in DMEM media, loaded onto the gradients, and centrifuged at 20,000 g for 1 hour. Density bands were determined using Pharmacia Biotech AB marker beads. Low ploidy factions were obtained at the 1.08 g/l density band of exponentially growing VSMCs. High ploidy fractions were obtained at the 1.04 g/l density band of 1-week colcemid-treated (100 ng/ml) VSMCs. Cell fractions were isolated by pipetting, washed twice in DMEM media, and processed for flow cytometry or Western analysis.
Analysis of cell-cycle checkpoint status. Matched sets of VSMC populations were incubated for a 1-2 populationdoubling time periods in media with the mitotic spindle inhibitor colcemid (100 ng/ml). Cell-cycle distribution of DNA content was determined by flow cytometry as described previously (57, 58) . When both total DNA content and newly synthesized DNA were determined, cells were labeled with 10 µM bromodeoxyuridine (BrdU) for 4 hours, trypsinized, counted, and fixed using 70% ethanol. Fixed cells were centrifuged and treated with 0.08% pepsin for the preparation of nuclei. The nuclear pellet was resuspended in 100 µl of a 1:5 dilution of antiBrdU FITC-conjugated Ab (Becton Dickinson), incubated for 30 minutes, washed, stained with 50 µg/ml propidium iodide (Aldrich Chemical Co., Milwaukee, Wisconsin, USA), and analyzed by flow cytometry for cell-cycle distribution of DNA content. Flow cytometry was carried out using a Coulter Elite ESP flow cytometer and analyzed using CellQuest software (Becton Dickinson), and cells (10 4 -4 × 10 4 per sample) were analyzed.
For karyotyping (57) , exponentially growing cells were exposed to 100 ng/ml colcemid for two population-doubling times, and then collected and incubated at room temperature for 30 minutes in hypotonic KCl plus sodium citrate, followed by fixation in methanol/acetic acid and staining with Giemsa; 16-39 spreads per VSMC population were examined.
Western blots. For Western blot analysis, cells were harvested and lysed in 1 ml lysis buffer-PBS containing 1% Triton X-100, 0.1% SDS, 1mM DTT, 1mM PMSF, and 1 µg/ml of the protease inhibitors aprotinin, leupeptin, and pepstatin A, followed by centrifugation at 1500 g for 5 minutes. Equal amounts of proteins were assayed at each condition as determined by Bradford protein assay (Bio-Rad, Hercules, California, USA). Electrophoresis was carried out at 20 mA constant current in 15% PAGE (BioRad). Proteins were transferred to Immobilon-P membranes (Millipore Corp., Bedford, Massachusetts, USA) and probed, following the recommendation of the manufacturers. Anti-Akt1 (Santa Cruz Biotechnologies), anticyclin B (Santa Cruz Biotechnologies), and anti-β actin (Sigma Chemical Co.) Ab's were employed at dilution of 1:500, 1:500, and 1:10,000, respectively, in PBS-5% dry milk. Membranes were hybridized overnight at 4°C. For detection, membranes were incubated for 1 hour in 1:10,000 or 1:5,000 dilutions of horseradish peroxidase-linked (HRP-linked) IgG (Santa Cruz). HRP-luminescence reactions were carried out using the enhanced chemiluminescence (ECL) kit (Amersham Corp., Burlington, Massachusetts, USA). Membranes were exposed to Hyperfilm (Eastman Kodak Co. Scientific Imaging Systems, New Haven, Connecticut, USA) and protein bands detected by autoradiography. Low-exposure autoradiographs were scanned with a densitometer (LKB-Wallac, Stockholm, Sweden) to determine peak areas.
Determination of VSMC hypertrophy. [ 3 H] leucine incorporation was carried out as described (26) . Briefly, VSMCs were made quiescent by incubation in 1% DMEM for 72 hours. Twenty-four hours before harvesting, [ 3 H] leucine (1 µCi/ml) (NEN Life Science Products, Boston, Massachusetts, USA) was added to the media. VSMCs were washed twice in PBS, proteins precipitated in 5% trichloroacetic acid, and [ 3 H] leucine incorporation determined using a LS 3801 scintillation counter (Beckman Instruments Inc., Fullerton, California, USA). Forward-scatter cell fluorescence and side-scatter cell fluorescence were determined using a Coulter Elite ESP flow cytometer and analyzed using CellQuest software (Becton Dickinson). VSMCs (4 × 10 4 per sample) were analyzed.
Results

Akt1 protein and activity are upregulated in VSMCs of three animal models of hypertension.
Akt1 protein expression was analyzed in VSMCs of hypertensive rats by Western blot analysis. Initial experiments compared SHR to normotensive WKY rats. SHR rates develop hypertension spontaneously and without exception by 7-15 weeks of age (59) . Vascular smooth muscle extracts were prepared from the aortas of 3-week-old and 4-month-old WKY and SHR rats and processed for Western blot analysis. Markedly greater Akt1 protein levels, approximately fivefold, were found in the SHR strain at both stages ( Figure  1 , a and b). In the older animals, an additional fastermigrating band was observed. This band was reactive with our secondary Ab and was designated "nonspecific" (Figure 1 , n.s.). To test whether genetic divergence might account for the differences in Akt1 protein expression between WKY and SHR rats, two additional models of experimental hypertension were investigated. In one of these models, the renin-angiotensin system was activated in WKY rats by clipping the left renal artery (referred to as Goldblatt's operation), a procedure that has been shown to induce VSMC hypertrophy and polyploidization at capacitance arteries (17) . Enhanced expression of Akt1 protein was observed in smooth muscle extracts from the aortas of Goldblatt rats relative to their mock-operated controls (Figure 1c ). We also investigated the expression level of Akt1 protein in Zucker lean and fa/fa rats. The Zucker fa/fa rat is a model of obesity and moderate hypertension (60) . Three-week-old animals expressed barely detectable Akt1 protein levels, with no differences between Zucker lean and fa/fa rats (not shown). However, threefold higher levels of Akt1 protein were found at 4 months in the hypertensive fa/fa group ( Figure 1d and Table 1 ). Furthermore, the increase in Akt1 protein level was accompanied by enhanced Akt1 kinase activity. Akt1 assays were performed using vascular smooth muscle extracts from 4-month-old WKY, SHR, and Zucker rats. The results of these experiments, shown in Figure 1e , demonstrated that changes in Akt1 kinase activity in vivo correlate with those of Akt1 protein levels. Maximal Akt1 kinase activity was found in SHR rats, approximately fourfold higher than agematched WKY controls. The development of hypertension in SHR and Goldblatt WKY rats is accompanied by VSMC polyploidiza-
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Figure 2
Akt1 upregulation is specifically localized to capacitance arteries. (a) Levels of Akt1 protein in vascular smooth muscle of 3-week-old SHR rats. Western blot analysis was performed as indicated in Figure 1 . tion at capacitance arteries (6, 17) , but this phenomenon has not been reported previously in Zucker fa/fa rats. Therefore, ploidy levels were determined in aortas of Zucker fa/fa rats using in situ DNA microdensitometry. WKY and Zucker lean rats were employed as negative controls and SHR rats as positive controls. Table 1 shows that hypertension in Zucker fa/fa rats is accompanied by VSMC polyploidization. Together, the results shown in Figure 1 and Table 1 demonstrate a correlation between hypertension, polyploidization, and elevated levels of Akt1 protein and activity in VSMCs. Previous studies have shown that the phenomena of VSMC polyploidization and hypertrophy are limited to vessels of capacitance function, such as the aorta and carotid arteries (52, (61) (62) (63) . Thus, we also investigated whether Akt1 protein was upregulated differentially depending upon localization within the vascular tree. Consistent with a role in hypertension-related hypertrophy and polyploidization, high levels of Akt1 protein expression were detected by Western analysis in the aorta and carotid arteries of SHR (Figure 2 ). In contrast, low levels of Akt1 protein were detected at small arteries, such as III and IV branches of the superior mesenteric artery. Moreover, immunohistochemical assays demonstrated that Akt1 upregulation was restricted to the medial smooth muscle layer of capacitance arteries (upper aorta), with background staining at the vascular adventitia (Figure 2) .
Akt1 promotes VSMC endoreduplication. In view of these results and the reported pro-proliferative and antiapoptotic properties of Akt1 (64), we hypothesized that an increase in Akt1 activity in VSMCs of hypertensive animals could contribute to their polyploidization. To test this hypothesis, Akt1 was overexpressed in VSMCs isolated from the aorta of 3-week-old normotensive WKY rats using an adenovirus vector that encodes wildtype murine Akt1 (Akt1 wt) (25, 35) . VSMCs were also infected with adenoviruses that encode the catalytic inactive Akt1 mutant T308A/S473A (Akt1 AA), or the β-galactosidase gene (β Gal). Overexpression of Akt1 was verified by Western blot analysis ( Figure 3 ). As expected, we observed an increase in basal Akt1 activity in VSMC-overexpressing wild-type Akt1, but not in those overexpressing the catalytic inactive Akt1 AA mutant (Figure 3) .
The adenovirus-infected VSMC populations were analyzed for their ability to control cell-cycle progression at the metaphase-to-anaphase transition, using the flow cytometry-based assay described previously (57) . Incubation of wild-type Akt1-overexpressing VSMCs (VSMC-Akt1 wt cells) for two population-doubling times in the presence of a mitotic inhibitor resulted in dramatic progression to octaploid DNA content (4N, Figure 4a ). In contrast, VSMCs expressing β-galactosidase or the catalytic inactive Akt1 AA mutant were able to arrest growth at 4N, with minor progression to 4N (Figure 4a) . Moreover, when primary VSMCs were infected with increasing moi's of wild-type Akt1 adenovirus, a direct correlation was observed between Akt1 transduction and VSMC polyploidization (Figure 4b) . Furthermore, double staining of total DNA content (propidium iodide staining) versus newly synthesized DNA (BrdU incorporation) indicated that VSMC-Akt1 wt underwent cell-cycle reentry at 4N DNA content (Figure 4c ). These results demonstrated that Akt1 overexpression promotes endoreduplication in VSMCs.
Overexpression of Ak1 causes altered mitotic spindle cell-cycle checkpoint status in VSMCs.
The fact that VSMCs overexpressing wild-type Akt1 may undergo endoreduplication indicates a loss of mitotic spindle cell-cycle checkpoint activity in these cells. The mitotic spindle cell-cycle checkpoint regulates exit from mitosis by controlling the metabolism of M-phase regulators, such as cyclin B (65) . When cells cannot segregate their chromosomes appropriately, the degradation of cyclin B and, consequently, the progression from mitosis to a new G1-phase, is delayed (58) . To determine the status of the mitotic checkpoint in Akt1-transduced VSMCs, we investigated the ability of these cells to regulate cyclin B turnover in response to the inhibition of their chromosomal segregation (58) . Cells were made quiescent and then stimulated to enter the cell cycle synchronously in the presence or absence of colcemid. In the absence of microtubule inhibitor, cyclin B protein levels oscillated similarly in all cell groups. Cyclin B protein reached maximal levels at 48 hours and decreased to barely detectable levels at 72 hours, indicating entry and exit from mitosis ( Figure 5 , a-c; no colcemid). In wild-type Akt1-transduced cells, cyclin B expression was observed as early as 24 hours, suggesting shortening of G1 or S cell-cycle phases (Figure 5c ; no colcemid), in agreement with previous reports (66) . Importantly, a differential ability to regulate cyclin B degradation in response to colcemid was observed ( Figure 5 , a-c; colcemid). In β-Gal and Akt1 mutant-transduced cells, cyclin B levels remained elevated for up to 120 hours. This delay in the onset of cyclin B degradation indicated the activity of the mitotic spindle cell-cycle checkpoint and was similar in length to what has been observed previously in normal human fibroblasts (58) . However, when wild-type Akt1-overexpressing VSMCs were incubated in colcemid, cyclin B levels declined between 48 hours and 72 hours. Thus, VSMCs with high Akt1 levels failed to maintain cyclin B levels in response to mitotic spindle depolymerization, demonstrating that overexpression of Akt1 alters the activity of the mitotic spindle cell-cycle checkpoint in VSMCs. Expression of a control protein, β-actin, in extracts from these cell groups was similar at all time points investigated (not shown).
Akt1 promotes VSMC polyploidization and hypertrophy. Although the results shown in Figures 4 and 5 demonstrate that Akt1 upregulation promotes endoreduplication in VSMCs, they do not provide formal proof of VSMC polyploidization. Thus, karyotypic analyses were performed to confirm whether or not overexpression of Akt1 is sufficient to induce polyploidization in VSMCs. Control and wild-type Akt1-transduced VSMC populations had a low number of polyploid cells (1-3%). However, when these cells were incubated in the presence of colcemid for two population-doubling time periods, a high polyploid fraction was observed in VSMCs transduced with wildtype Akt1, but not with Akt1 AA or βGal adenovirus (Figure 6b ). Of note, chromosomal counts were multiples of the diploid number, supporting endoreduplication as the mechanism of polyploidization in VSMCs. Subsequent experiments, shown in Figure 6c , investigated the ploidy content of control and wildtype Akt1-transduced VSMCs after successive passage in culture. Higher ploidy fractions were found in VSMCs transduced with wild-type Akt1. Thus, cell populations overexpressing wild-type Akt1 may under-
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The go spontaneous polyploidization in tissue culture, a phenomenon described previously in VSMCs isolated from hypertensive animals (67). Since polyploid VSMCs are hypertrophic, we extended our observations to the analysis of the effects of Akt1 on VSMC size and protein synthesis. Forwardscatter cell (FSC) fluorescence flow cytometry demonstrated a 36% increase in cell size in wild-type Akt1-transduced VSMCs (Figure 7a) . Furthermore, analysis of [ 3 H]-leucine incorporation to protein demonstrated a 50% increase in protein synthesis in these cells (Figure 7b ). Taken together, the results shown in Figures 6 and 7 demonstrate that overexpression of Akt1 is sufficient to induce polyploidization and hypertrophy in VSMCs.
Akt1 function is required for angiotensin II-induced VSMC polyploidization. Multiple growth factors have been shown to induce Akt1 activity in VSMCs (26, (48) (49) (50) (68) (69) (70) (71) . We investigated the ability of angiotensin II (26, (48) (49) (50) , PDGF BB (50, 69), and TGF-β (50), to modulate the onset of polyploidization in VSMCs. As shown in Figure 8a , angiotensin II, but not PDGF BB or TGF-β, promoted VSMC polyploidization. Furthermore, addition of PDGF BB or TGF-β decreased the level of angiotensin II-induced VSMC polyploidization (Figure 8a) . To determine whether or not angiotensin II-induced polyploidization was mediated by Akt1, VSMCs were transduced with control or Akt1 AA mutant adenoviruses before stimulation. Expression of Akt1 AA blocked the polyploidization of VSMCs induced by angiotensin II (Figure 8b) . Thus, these results demonstrated that Akt1 function is required for angiotensin II-induced VSMC polyploidization.
Discussion
Most plants and animals generate tissue-specific subpopulations of polyploid cells that are larger than their diploid counterparts (72) . However, little is known about the molecular events that promote tissue-specific hypertrophy and polyploidization. Here we provide evidence for a role of Akt1 in VSMC hypertrophy and polyploidization, phenomena that occur at capacitance arteries during hypertension (6) (7) (8) (9) (10) 17) . High levels of Akt1 protein and activity were observed in aortas of hypertensive SHR, Goldblatt-WKY, and Zucker fa/fa rats, which also displayed polyploidization. The increase in basal Akt1 activity, four to fivefold higher in SHR related to age-matched WKY controls, correlates well with the elevation in Akt1 protein expression. These data provide correlative evidence that Akt1 is involved in VSMC polyploidization in several experimental models of hypertension. Consistent with these results, recent data from Jiang and coworkers demonstrate that the PI 3-kinase/Akt pathway is reduced in microvessels of Zucker fa/fa rats, whereas a moderate increase in activity was observed in the aorta (73) .
To determine the functional significance of the elevated Akt1 levels in vascular smooth muscle, this protein was overexpressed in VSMCs isolated from the aortas of normotensive rats. Overexpression of wild-type Akt in VSMCs increased Akt1 activity approximately tenfold, within the range of induction observed in smooth muscle cells incubated in the presence of H 2 O 2 or angiotensin II (26) . Importantly, overexpression of wild-type, but not a catalytic inactive, Akt1 abrogated the activity of the mitotic spindle cell-cycle checkpoint in VSMCs, with corresponding perturbations in the cyclin B expression and DNA endoreduplication. Furthermore, enhanced expression of Akt1 was sufficient to induce polyploidization and hypertrophy in VSMCs. The fact that Akt1 promotes the progression of mitosis (M phase) parallels other growth-related properties of this protein. Akt1 has been shown to activate NF-κB activity (46) and c-fos (74) , positive regulators of the progression through G1 cell-cycle phase (75, 76) . Akt1 also activates E2F, a regulator of the G1/S transition (44) . Collectively, these data demonstrate that Akt1 promotes cell growth by acting at multiple stages of the cell cycle. Akt1 appears to predispose VSMCs to polyploidization because no cell-cycle differences in Akt1 protein levels in VSMCs were found, nor were differences found in Akt levels between tetraploid versus diploid VSMCs (not shown). These data resemble our previous observations in patients with Li-Fraumeni syndrome who carry p53 mutations (57) and strongly suggest that Akt1 does not affect directly the chromosomal segregation machinery, but the pathways that regulate VSMC ploidy content.
Our results indicate that overexpression of Akt1 in VSMCs overrides the activity of the mitotic spindle checkpoint, facilitating unscheduled degradation of cyclin B, cell-cycle reentry (endoreduplication), and polyploidization. At least two molecular mechanisms can account for these effects of Akt1. First, Akt may directly modulate the expression of cell-cycle regulatory proteins. The metabolism of the cyclin B-Cdc2 complex is known to be regulated by its interaction with Cks(s) [in Homo sapiens, CKsHs(s)] (77, 78) and by spindle sensor proteins, such as MAD2 (79) (80) (81) . Therefore, further investigation on the effects of Akt1 on these and other mitotic regulatory factors (82) may reveal the mechanism of cyclin B modulation by Akt1. In addition, polyploid VSMCs may be eliminated by the activity of the postmitotic checkpoint, an apoptotic pathway that target cells that escape the control of the mitotic spindle checkpoint (83, 84) . Therefore, the antiapoptotic properties of Akt may be necessary to maintain the viability of polyploid VSMCs. In support of this hypothesis, Akt1 is a regulator of the bcl-2 family protein, BAD (37) , and Bcl2 family members are known to promote polyploidization in mesenchymal cells (85) .
As shown here, angiotensin II, but not PDGF BB or TGF-β, promoted Akt-dependent VSMC polyploidization. The fact that PDGF BB and TGF-β, activators of Akt signaling, fail to induce VSMC polyploidization may be related to the ability of these factors to activate additional signal-transduction pathways. For example, PDGF BB activates ERK and p38MAPK activities, which may oppose Akt signaling in smooth muscle (69) . Importantly, Mek and p42 MAPK have been shown to trigger G2/M arrest in some systems (86) . Likewise, TGF-β inhibits WKY VSMC polyploidization (87, 88) , and this may be mediated by downregulation of Cks1 (89) . Therefore, we propose that Akt signaling is both essential and sufficient for VSMC hypertrophy and polyploidization, but this activity can be overridden by factors that promote MAPK signaling and/or that modulate the expression of other cell-cycle regulatory proteins. Consistent with this hypothesis, we found that PDGF BB and TGF-β decrease angiotensin II-induced VSMC polyploidization.
In conclusion, we demonstrate that Akt1 protein levels and kinase activity are elevated in VSMCs that are predisposed to, or undergoing, hypertrophy in several animal models of hypertension. Although it is shown here that Akt1 is sufficient for the induction of VSMC hypertrophy and polyploidization, an unresolved issue is the nature of the causal relationship between polyploidization and hypertrophy. On one hand, hypertrophy, i.e., cell enlargement, may induce polyploidization. Alternatively, polyploidization may be an essential feature of the hypertrophic process. Evidence for the latter hypothesis comes from the recent finding of DNA ploidy-driven mechanisms of control of gene expression (90) . In this study, an increase in cell size was explained by the longer G1 cell-cycle phase of polyploid yeast cells, which express low levels of G1 cyclins. Consistent with this hypothesis is the observation that tetraploid VSMCs exhibit longer population-doubling rates than their diploid counterparts (91, 92) . Therefore, further investigation on the functions of Akt1 should provide additional information regarding the interrelationship between VSMC hypertrophy and polyploidization, and the molecular mechanisms that control these processes.
